Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Stock
Equities
002932
CNE1000033Q7
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
21 CNY | -0.94% | +1.01% | -8.58% |
Sales 2021 | 2.83B 392M | Sales 2022 | 10.53B 1.46B | Capitalization | 8.95B 1.24B |
---|---|---|---|---|---|
Net income 2021 | 1.41B 196M | Net income 2022 | 4.21B 583M | EV / Sales 2021 | 2.09 x |
Net cash position 2021 | 1.85B 256M | Net cash position 2022 | 4.3B 596M | EV / Sales 2022 | 0.44 x |
P/E ratio 2021 |
4.99
x | P/E ratio 2022 |
2.1
x | Employees | 1,547 |
Yield 2021 |
6.08% | Yield 2022 |
9.08% | Free-Float | 50.59% |
1 day | -0.94% | ||
1 week | +1.01% | ||
Current month | +1.01% | ||
1 month | -4.02% | ||
3 months | +24.11% | ||
6 months | -11.05% | ||
Current year | -8.58% |
Managers | Title | Age | Since |
---|---|---|---|
Li Li Chen
CEO | Chief Executive Officer | 50 | 13-10-22 |
Guo Hui Zhou
DFI | Director of Finance/CFO | 40 | 21-08-17 |
Ying Wang
BRD | Director/Board Member | - | 13-10-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jin Cheng Xie
BRD | Director/Board Member | 63 | 21-11-25 |
Xian Wang Shi
BRD | Director/Board Member | 56 | 22-10-20 |
Li Li Chen
CEO | Chief Executive Officer | 50 | 13-10-22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.09% | 12 M€ | -16.71% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 21 | -0.94% | 5 182 978 |
24-05-07 | 21.2 | +2.32% | 6,680,839 |
24-05-06 | 20.72 | -0.34% | 4,428,592 |
24-04-30 | 20.79 | +1.81% | 5,035,486 |
End-of-day quote Shenzhen S.E., May 07, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-8.58% | 683M | |
-1.49% | 12.71B | |
+0.13% | 8.37B | |
-1.12% | 5.4B | |
+20.18% | 5.27B | |
-0.74% | 4.63B | |
-54.68% | 3.13B | |
+24.56% | 2.77B | |
-8.47% | 2.25B | |
-1.86% | 1.95B |
- Stock Market
- Equities
- 002932 Stock